Ashley Mc Evoy is EVP, WW Chair, MedTech of JOHNSON & JOHNSON. Currently has a direct ownership of 52,037 shares of JNJ, which is worth approximately $8.63 Million. The most recent transaction as insider was on Aug 23, 2023, when has been sold 2,787 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 52K
0% 3M change
0% 12M change
Total Value Held $8.63 Million

Ashley McEvoy Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 23 2023
SELL
Sale (or disposition) back to the issuer
-
2,787 Reduced 5.08%
52,037 Common Stock
Feb 13 2023
SELL
Payment of exercise price or tax liability
$1,159,667 $162.01 p/Share
7,158 Reduced 11.55%
54,824 Common Stock
Feb 13 2023
BUY
Grant, award, or other acquisition
-
17,994 Added 22.5%
61,982 Common Stock
Feb 10 2023
SELL
Payment of exercise price or tax liability
$133,391 $162.08 p/Share
823 Reduced 1.84%
43,988 Common Stock
Feb 10 2023
BUY
Exercise of conversion of derivative security
-
2,999 Added 6.27%
44,811 Common Stock
Nov 30 2022
SELL
Open market or private sale
$12,888,716 $175.78 p/Share
73,323 Reduced 63.68%
41,812 Common Stock
Nov 30 2022
BUY
Exercise of conversion of derivative security
$5,318,850 $72.54 p/Share
73,323 Added 38.91%
115,135 Common Stock
Feb 15 2022
SELL
Payment of exercise price or tax liability
$1,035,485 $165.89 p/Share
6,242 Reduced 12.99%
41,812 Common Stock
Feb 15 2022
BUY
Exercise of conversion of derivative security
-
15,806 Added 24.75%
48,054 Common Stock
Feb 14 2022
SELL
Payment of exercise price or tax liability
$133,729 $168.85 p/Share
792 Reduced 2.4%
32,248 Common Stock
Feb 14 2022
BUY
Exercise of conversion of derivative security
-
2,885 Added 8.03%
33,040 Common Stock
Feb 12 2021
SELL
Payment of exercise price or tax liability
$774,443 $165.55 p/Share
4,678 Reduced 13.43%
30,155 Common Stock
Feb 12 2021
BUY
Exercise of conversion of derivative security
-
13,136 Added 27.38%
34,833 Common Stock
Jul 28 2020
SELL
Open market or private sale
$4,276,630 $147.47 p/Share
29,000 Reduced 57.22%
21,681 Common Stock
Feb 13 2020
SELL
Payment of exercise price or tax liability
$877,483 $150.46 p/Share
5,832 Reduced 10.32%
50,664 Common Stock
Feb 13 2020
BUY
Exercise of conversion of derivative security
-
13,747 Added 19.57%
56,496 Common Stock
Feb 03 2020
SELL
Payment of exercise price or tax liability
$2,300,275 $149.32 p/Share
15,405 Reduced 26.49%
42,748 Common Stock
Feb 03 2020
BUY
Exercise of conversion of derivative security
-
38,650 Added 39.93%
58,153 Common Stock
Feb 11 2019
SELL
Payment of exercise price or tax liability
$472,081 $131.94 p/Share
3,578 Reduced 15.53%
19,468 Common Stock
Feb 11 2019
BUY
Grant, award, or other acquisition
-
1,237 Added 5.09%
23,046 Common Stock
Feb 11 2019
BUY
Exercise of conversion of derivative security
-
7,541 Added 25.69%
21,809 Common Stock
Feb 08 2019
SELL
Payment of exercise price or tax liability
$240,768 $132.0 p/Share
1,824 Reduced 11.33%
14,268 Common Stock
Feb 08 2019
BUY
Exercise of conversion of derivative security
-
6,599 Added 29.08%
16,092 Common Stock

Also insider at

PG
PROCTER & GAMBLE Co Consumer Defensive
AM

Ashley Mc Evoy

EVP, WW Chair, MedTech
New Brunswick, NJ

Track Institutional and Insider Activities on JNJ

Follow JOHNSON & JOHNSON and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JNJ shares.

Notify only if

Insider Trading

Get notified when an Johnson & Johnson insider buys or sells JNJ shares.

Notify only if

News

Receive news related to JOHNSON & JOHNSON

Track Activities on JNJ